9th January 2018: NeRRe Therapeutics CEO, Dr Mary Kerr, presents at the Biotech Showcase, 11:30 AM Franciscan – B (Ballroom Level), Hilton San Francisco, San Francisco, CA 94102, USA2018-01-052018-09-14https://www.nerretherapeutics.com/wp-content/uploads/2018/09/logo.pngNeRRe Therapeuticshttps://www.nerretherapeutics.com/wp-content/uploads/2018/09/logo.png200px200px
9th January 2018: NeRRe Therapeutics CEO, Dr Mary Kerr, presents at the Biotech Showcase, 11:30 AM Franciscan – B (Ballroom Level), Hilton San Francisco, San Francisco, CA 94102, USA
NeRRe Therapeutics is a UK based clinical-stage company developing a unique portfolio of neurokinin (NK) receptor antagonists for the treatment of common debilitating conditions caused by neuronal hypersensitivity.